APA

Marques E., Englund J. I., Tervonen T. A., Virkunen E., Laakso M., Myllynen M., Mäkelä A., Ahvenainen M., Lepikhova T., Monni O., Hautaniemi S. & Klefström J. (20160815). Par6G suppresses cell proliferation and is targeted by loss-of-function mutations in multiple cancers. : Oncogene.

Chicago

Marques E, Englund J I, Tervonen T A, Virkunen E, Laakso M, Myllynen M, Mäkelä A, Ahvenainen M, Lepikhova T, Monni O, Hautaniemi S and Klefström J. 20160815. Par6G suppresses cell proliferation and is targeted by loss-of-function mutations in multiple cancers. : Oncogene.

Harvard

Marques E., Englund J. I., Tervonen T. A., Virkunen E., Laakso M., Myllynen M., Mäkelä A., Ahvenainen M., Lepikhova T., Monni O., Hautaniemi S. and Klefström J. (20160815). Par6G suppresses cell proliferation and is targeted by loss-of-function mutations in multiple cancers. : Oncogene.

MLA

Marques E, Englund J I, Tervonen T A, Virkunen E, Laakso M, Myllynen M, Mäkelä A, Ahvenainen M, Lepikhova T, Monni O, Hautaniemi S and Klefström J. Par6G suppresses cell proliferation and is targeted by loss-of-function mutations in multiple cancers. : Oncogene. 20160815.